-+ 0.00%
-+ 0.00%
-+ 0.00%

BlossomHill Therapeutics adopts amended, restated bylaws ahead of IPO close

PUBT·08/10/2026 20:05:38
Listen to the news
BlossomHill Therapeutics adopts amended, restated bylaws ahead of IPO close
  • Blossomhill Therapeutics adopted amended and restated bylaws effective Aug. 10, 2026, tied to the closing of its IPO.
  • The company also filed an amended and restated certificate of incorporation in Delaware, effective immediately before the IPO close.
  • The IPO closed Aug. 10 with 9,375,000 common shares sold at $16 per share, generating about $150 million in gross proceeds.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Blossomhill Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001193125-26-342316), on August 10, 2026, and is solely responsible for the information contained therein.